These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2258095)

  • 21. [Glucophage symposium. NIDD today. International symposium, 7-8 September 1990, Helsingor, Denmark].
    Klin Wochenschr; 1990 Nov; 68(22 Suppl):1-4. PubMed ID: 2136304
    [No Abstract]   [Full Text] [Related]  

  • 22. [Insulin retard].
    ROTTEGLIA E
    Boll Chim Farm; 1953 Jul; 92(7):262-3. PubMed ID: 13093809
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experiences with a new retard insulin].
    BELLWINKEL HW
    Dtsch Med Wochenschr; 1954 Dec; 79(51):1896-9. PubMed ID: 14352723
    [No Abstract]   [Full Text] [Related]  

  • 24. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.
    Lee A; Morley JE
    Obes Res; 1998 Jan; 6(1):47-53. PubMed ID: 9526970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity.
    Seifarth C; Schehler B; Schneider HJ
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):27-31. PubMed ID: 23147210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial hyperglycemia was ameliorated by taking metformin 30 min before a meal than taking metformin with a meal; a randomized, open-label, crossover pilot study.
    Hashimoto Y; Tanaka M; Okada H; Mistuhashi K; Kimura T; Kitagawa N; Fukuda T; Majima S; Fukuda Y; Tanaka Y; Yamada S; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Nakamura N; Fukui M
    Endocrine; 2016 May; 52(2):271-6. PubMed ID: 26518190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin increases urinary sodium excretion by reducing phosphorylation of the sodium-chloride cotransporter.
    Hashimoto H; Nomura N; Shoda W; Isobe K; Kikuchi H; Yamamoto K; Fujimaru T; Ando F; Mori T; Okado T; Rai T; Uchida S; Sohara E
    Metabolism; 2018 Aug; 85():23-31. PubMed ID: 29510178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual Functioning and Depressive Symptoms in Women with Diabetes and Prediabetes Receiving Metformin Therapy: A Pilot Study.
    Krysiak R; Drosdzol-Cop A; Skrzypulec-Plinta V; Okopień B
    Exp Clin Endocrinol Diabetes; 2017 Jan; 125(1):42-48. PubMed ID: 27711958
    [No Abstract]   [Full Text] [Related]  

  • 29. Unexpectedly long half-life of metformin elimination in cases of metformin accumulation.
    Kajbaf F; Bennis Y; Hurtel-Lemaire AS; Andréjak M; Lalau JD
    Diabet Med; 2016 Jan; 33(1):105-10. PubMed ID: 26337524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and insomnia: an interesting story.
    Wiwanitkit S; Wiwanitkit V
    Diabetes Metab Syndr; 2011; 5(3):160. PubMed ID: 22813571
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients.
    Snorgaard O; Køber L; Carlsen J
    J Intern Med; 1997 Nov; 242(5):407-12. PubMed ID: 9408071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of timing on gliclazide absorption and action.
    Ishibashi F; Takashina S
    Hiroshima J Med Sci; 1990 Mar; 39(1):7-9. PubMed ID: 2373640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin extended-release versus immediate-release: An international, randomized, double-blind, head-to-head trial in pharmacotherapy-naïve patients with type 2 diabetes.
    Aggarwal N; Singla A; Mathieu C; Montanya E; Pfeiffer AFH; Johnsson E; Zhao J; Iqbal N; Bailey C
    Diabetes Obes Metab; 2018 Feb; 20(2):463-467. PubMed ID: 28857388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Glucophage-retard].
    Francomme P; Massamba M; Parise M
    Soins; 1987 Feb; (495-496):I-II. PubMed ID: 3648946
    [No Abstract]   [Full Text] [Related]  

  • 35. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus.
    Guo M; Mi J; Jiang QM; Xu JM; Tang YY; Tian G; Wang B
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):650-6. PubMed ID: 24862430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of metformin in type 1 diabetes: a systematic review of efficacy.
    Vella S; Buetow L; Royle P; Livingstone S; Colhoun HM; Petrie JR
    Diabetologia; 2010 May; 53(5):809-20. PubMed ID: 20057994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bedtime administration of metformin may reduce insulin requirements].
    Ravina A; Minuchin O
    Harefuah; 1990 Oct; 119(7-8):200-3. PubMed ID: 2258095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.